Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|8|1081-1087

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.8, 2015-08, pp. : 1081-1087

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite

Vinorelbine and Carboplatin in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 976-982

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 145-150

Karger

Access to resources Recommend Favorite